S h a n n o n

O C o n n o r P a g e | 1

Shannon L. OConnor, BA

1107 Bryan St.

Columbia, SC 29201
513-746-1366
shannonloc@gmail.com

819 Barnwell St.

Columbia, SC 29201

803-777-5676
slo@email.sc.edu

Education

2015-Present



2011-2013







2010-2011

University of South Carolina Columbia, South Carolina

School Psychology Doctoral Student

University of CincinnatiCincinnati, Ohio

Bachelor of Arts in Psychology
GPA: 3.81 (Psychology GPA: 3.94)
Graduated: December 2013

University of Cincinnati Clermont CollegeBatavia, Ohio

Post Secondary Enrollment Options Program

Honors and Memberships

2013

Debeck Linn Fellowship Recipient

2012-2013

Golden Key International Honor Society Member

2011-2013

Cincinnatus Scholarship Recipient

2010-2013

University of Cincinnati, McMicken College of Arts and Sciences Deans List

Research Experience

October 2013-
Present

Cincinnati Childrens Hospital Medical Center, Division of

Psychiatry
Role: Clinical Research Coordinator II
Double-Blind Placebo-Controlled Study of Acamprosate in Autism
Primary Investigator: Craig Erickson, MD
Autism Speaks Treatment Grant
Study investigating the effectiveness of the drug acamprosate to reduce core social skills
deficits associated with ASD.
Administered eye-tracking paradigms to participants. Coordinated study drug, obtained
study drug from investigational pharmacy, distributed study drug to participants,
administered dosing instructions, and calculated study drug compliance and
accountability. Coordinated phone, and clinic recruitment, screened participants, and
scheduled study visits. Reviewed informed consent with participants and guardians, and
administered measures (e.g., Aberrant Behavior Checklist, Vineland Adaptive Behavior

 S h a n n o n O C o n n o r P a g e | 2

Scales (VABS), and Childrens Yale-Brown Obsessive Compulsive Scale for Autism
Spectrum Disorders). Coordinated and completed IRB documentation. Created database
for data management, and entered study data using REDCap.

Double-Blind, Placebo-Controlled Proof of Concept Study of Acamprosate in Youth
with Fragile X Syndrome
Primary Investigator: Craig Erickson, MD
John Merck Fund Translation Research Program Award
Multisite study investigating the effectiveness of the drug acamprosate to reduce
inattention/hyperactivity and social impairment in youth with FXS.
Administered eye-tracking paradigms to participants. Coordinated study drug, obtained
study drug from investigational pharmacy, distributed study drug to participants,
administered dosing instructions, and calculated study drug compliance and
accountability. Communicated with other study site to ensure accuracy and consistency.
Coordinated phone, and clinic recruitment, screened participants, and scheduled study
visits. Reviewed informed consent with participants and guardians, and administered
measures (e.g., Vineland Adaptive Behavior Scales (VABS), Childrens Yale-Brown
Obsessive Compulsive Scale for Autism Spectrum Disorders, and Pediatric Anxiety Rating
Scale). Coordinated and completed IRB documentation. Created database for data
management, and entered study data using REDCap.

Characterizing Autism Spectrum Disorders
Primary Investigator: Craig Erickson, MD
Simons Foundation Autism Research Initiative Pilot Award
Study examining extracellular signal-related kinase (ERK) in kids with and without ASD.
Coordinated phone and clinic recruitment, scheduled study visits, and administered
measures (e.g., Aberrant Behavior Checklist, Social Communication Questionnaire).
Screened participants, reviewed informed consent with participants and guardians, and
administered behavioral testing measures to participants, including the Vineland
Adaptive Behavior Scales (VABS). Administered eye-tracking paradigms to participants.
Maintained subject logs and charts, extracted data from participants medical charts, and
scored behavioral measures. Observed diagnostic and psychological testing, including
the Autism Diagnostic Observation Schedule (ADOS) and clinical diagnostic interviews.
The Divisions of Psychiatry and Biostatistics and Epidemiology
Developmental Disabilities Clinic Repository (DDCR): A Personalized Medicine-
based Repository of Biological Samples, Genetic and Clinical Data from Individuals
with Developmental Disabilities and Non-Developmentally Disabled Controls
Primary Investigator: Craig Erickson, MD
Study collecting biological and phenotypic data from children with developmental
disorders and their family members.
Coordinated phone and clinic recruitment, scheduled study visits, and administered
measures (e.g., Aberrant Behavior Checklist, Social Communication Questionnaire).
Screened participants, reviewed informed consent with participants and guardians,
administered testing measures to participants, including the Vineland Adaptive Behavior
Scales (VABS). Administered cognitive testing to participants (e.g. DAS-II Early Years and
School Aged). Administered eye-tracking paradigms to participants. Obtained
developmental, medical and family history from participants. Maintained subject logs
and charts, extracted data from participants medical charts, and scored behavioral
measures. Coordinated and completed IRB documentation. Observed diagnostic and

 S h a n n o n O C o n n o r P a g e | 3

psychological testing, including the Autism Diagnostic Observation Schedule (ADOS) and
clinical diagnostic interviews.
SynapDx Autism Spectrum Disorder Gene Expression Analysis (STORY) Study
Principal Investigator: Logan Wink, MD
SynapDx Inc. sponsored study to develop a blood test to maximize agreement between the
classification and clinical assessment of autism spectrum disorders.
Coordinated phone and clinic recruitment, study visits, screened participants, and
reviewed informed consent with participants and guardians. Obtained developmental
and medical history from participants. Maintained participant logs and charts and
extracted data from participants medical charts. Observed diagnostic and psychological
testing, including the Autism Diagnostic Observation Schedule (ADOS), and clinical
diagnostic interviews.

August 2012-
May 2013

January 2012-
December 2013

Cincinnati Childrens Hospital Medical Center, Center for ADHD

Role: Primary Counselor
Multisite Study of School-Based Treatment Approaches for
ADHD Adolescents
Primary Investigator: Joshua Langberg, Ph.D. and Steven Evans, Ph.D.
National Institute of Mental Health (NIMH). R01MH082865
2/2 Multisite Study of School Based Treatment Approaches for ADHD Adolescents.
Trained on implementing study skills, social skills, and behavioral management of
adolescents with ADHD. Collaborated directly with students, teachers, and parents to
develop academic and social treatment plans. Implemented organizational, academic,
and interpersonal skills interventions 6-9 hours a week. Applied behavior modification
techniques using behavior calls and positive and negative reinforcement. Collected and
presented data on students progress.

University of Cincinnati, Childrens Cognitive Research Lab
Role: Research Assistant
The emergence of congruence in childrens beliefs about
sinking: The role of entropy
Primary Investigator: Heidi Kloos, Ph.D.
Study examining how typically developing children understand and use Gestalts when
presented with false and abstract information.
Recruited participants from local schools, daycares, and local museum center. Tested
participants using an interactive computer program. Maintained participant logs.
Created a data summary from over 200 participants using Microsoft Excel to be used in
publication.

Developmental Change in the Dynamics of Spontaneous Entrainment in 5-, 7-, and
9-year-olds
Primary Investigator: Heidi Kloos, Ph.D.
Study examining if the way in which characteristics of spontaneous motor entrainment
change in children from 5 years to 9 years is consistent with dynamic systems theory.
Recruited participants from local schools, daycares, and local museum center. Tested
participants using Xbox Kinect technology to track arm motion. Maintained participant
logs, and managed participant data using Microsoft Excel.

 S h a n n o n O C o n n o r P a g e | 4

Clinical Experience

July 2014

Autism Diagnostic Observation Schedule, Second Edition Training

Instructor: Amie Duncan, Ph.D.
Cincinnati Childrens Hospital, Division of Psychiatry

Completed three day training in administration and interpretation of ADOS-II.


June 2014-

IQ Administration Training
Present

Instructor: Rebecca Shaffer, PsyD
Cincinnati Childrens Hospital Medical Center
Trained on the administration of the Differential Ability Scales-II (DAS-II) Early Years
and School Age batteries. Observed live administrations by a psychologist and reviewed
scoring procedures. Administered IQ assessments with a psychologist shadowing and
received approval of independent administration with research participants.

September 2012-
Undergraduate Clinic Research Practicum
May 2013

Supervisor: Jannel Phillips, Ph.D.
Cincinnati Childrens Hospital Medical Center Department of


Developmental and Behavioral Pediatrics
Co-facilitated the administration of neuropsychological evaluations including Bailey
Scales of Infant Development, Leiter-R and DAS-II Early Years. Scored multiple
psychological protocols such as, CBCLs, SIB-R, BASQ-2, Vineland-II, Brief (all versions),
GARS-II, GADS, Vanderbilt, ASDS. Observed administration of neuropsychological
evaluations of infants, toddlers, and adolescents with a wide range of developmental and
behavioral disorders. Observed implementation of PCIT therapy. Observed severe
behavior treatment interventions.

September 2012-
Executive Functioning Group Therapy
October 2012
Facilitator: Stacey Morrison, PsyD
Cincinnati Childrens Hospital Medical Center Department of Developmental and
Behavioral Pediatrics

Co-facilitated a 10-week group intervention for males with executive functioning deficits
ages 8-11 years old. Intervention goals included social skills, appropriate conversation,
appropriate body language, self-monitoring and, self-regulation.

Xxxbbxxxnnbbbbbnnxxxxxxxx Posters Presented xxxx.hxxxxxxxxbbxbxxxxbxxx

Amaral, J.L., Kloos, H., Collins, H., OConnor, S., McCalister, S., & Luzzi, C. D. (2013, July). Shape Categorization in
Autism: Does it follow a pattern of typical development? Paper presented at Cognitive Science Society
Annual Conference, Berlin, Germany.

McAlister, S., OConnor, S., Felix, A., Duvall, O., Amaral, J. L., Kloos, H. (2013, April). The gestalt of abduction in
childrens nave reasoning about physics. Poster presented at the undergraduate research conference of
the University of Cincinnati, Cincinnati, OH.

McAlister, S., OConnor, S., Gallenstein, A., Collins, S., Amaral, J. L M.S. M.A.., Kloos, H. (2012, June). The gestalt of
abduction in childrens nave reasoning about physics pilot data. Poster presented at the undergraduate
research conference of the University of Cincinnati, Cincinnati, OH.

 S h a n n o n O C o n n o r P a g e | 5

Professional Development

December 2013-
Present





September 2014

September 2014



May 2014

May 2014

The Kelly OLeary Center for Autism Spectrum Disorders (TKOC) Autism
Research Round Table Discussions
Cincinnati Childrens Hospital Medical Center
Moderator: Craig Erickson, MD
Bi-monthly, interdisciplinary meetings featuring research conducted across
developmental pediatrics, speech/language pathology, occupational therapy, neurology
and psychology.
Fragile X Carrier Conference
Cincinnati Childrens Hospital, Division of Psychiatry
Presenters: Deborah Hall MD, Ph.D. Rush University Medical School and Stephanie
Sherman, Ph.D. Emory University
Presentations on Fragile X-associate Premature Ovarian Insufficiency and Fragile X-
associate Tremor/Ataxia Syndrome. Biological and genetic mechanisms surrounding
each of these disorders.
Targeting the P13K complex in Fragile X Syndrome
Cincinnati Childrens Hospital Division of Psychiatry, Autism Research Seminar
Presenter: Nina Gross, Ph.D.
A 6-week, Randomized, Multicenter, Double-blind, Parallel, Flexed- and Fixed-dose
Study of MG01CI (Metadoxine Extended-release) 700 mg and 1400 mg Compared
with Placebo in Adults and Adolescents with Fragile X Syndrome
Philadelphia, PA
Attended a three-day investigator/coordinator meeting by Alcobra Pharmaceuticals.
Trained on execution of protocol procedures. Trained on behavioral and outcome
measures to be obtained during study visits (e.g. Attention Deficit Hyperactivity Disorder
Rating Scale IV).
A comprehensive dataset of CCHMC autism spectrum disorder patients: current
projects and future potential
Cincinnati Childrens Hospital Medical Center, Autism Research Seminar
Presenter: Katherine Bowers, Ph.D.

March 2013

Daily Living Skills Deficits in Adolescents with Autism Spectrum Disorder:

Implications for Adult Outcomes and Interventions
Cincinnati Childrens Hospital Medical Center, Autism Research Seminar
Presenter: Amie Duncan, Ph.D.

Teaching Experience

May 2013-
July 2013

Psychology of Gender
University of Cincinnati
Instructor: Nancy Rogers, Ph.D.
Teaching Assistant responsible for responding to students questions and concerns and
grading assignments.

 S h a n n o n O C o n n o r P a g e | 6

August 2013-
December 2013

Leading Diversity
University of Cincinnati
Instructor: Nancy Rogers, Ph.D.
Teaching Assistant responsible for responding to students questions and concerns,
grading assignments, facilitating online discussion boards and group projects.

Volunteer

2011-2012
2012-2013
2012-2014
2014

Visionaries and Voices

Bearcat Buddy Tutoring Program
Walk Now for Autism Speaks
Autism and All Special Needs Expo